AHL Investment Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$5K 176
2021
Q4
$5K Buy
+100
New +$4.03K ﹤0.01% 263

Other funds holding IRMD

AHL Investment Management's IRMD Position: Q1 2022 in Review

AHL Investment Management sold out of iRadimed (IRMD) in Q1 2022, closing a stake of 100 shares — an estimated $5K sold.

AHL Investment Management first reported a position in IRMD in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 103 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

  • AHL Investment Management reported no remaining iRadimed position as of Q1 2022 after selling out during the quarter.
  • AHL Investment Management sold 100 iRadimed shares in Q1 2022, an estimated $5K.
  • AHL Investment Management first reported a position in iRadimed in Q4 2021 and held it in 1 quarter.
  • AHL Investment Management's iRadimed position peaked at $5K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.